CoChat

Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes

Open access

The DOI matches its Crossref record; 15 of the 16 references it cites were found in a registry or an index; 12 of the 23 sources its claims cite were checked for support.

Abstract

OBJECTIVE: Use of Carpenter-Coustan compared with National Diabetes Data Group criteria increases the number of women diagnosed with gestational diabetes mellitus (GDM) by 30-50%, but whether treatment of this milder GDM reduces adverse outcomes is unknown. We explored the effects of the diagnostic criteria used on the benefits of GDM treatment. METHODS: This was a secondary analysis of a randomized trial for treatment of mild GDM diagnosed using Carpenter-Coustan criteria. We evaluated the effect of treatment within two mutually exclusive diagnostic groups: 1) women who met the stricter National Diabetes Data Group as well as Carpenter-Coustan criteria (National Diabetes Data Group), and 2) those diagnosed by Carpenter-Coustan but not meeting National Diabetes Data Group criteria (Carpenter-Coustan only). Maternal outcomes examined were pregnancy-induced hypertension, shoulder dystocia, maternal weight gain, and cesarean delivery. Neonatal outcomes were large for gestational age, macrosomia (greater than 4,000 g), fat mass, small for gestational age, and a composite outcome of perinatal death, birth injury, hypoglycemia, hyperbilirubinemia, and hyperinsulinemia. Analysis of variance or the Breslow-Day test, as appropriate, was used to test for the interaction between diagnostic criteria and GDM treatment on the outcomes of interest. RESULTS: Of 958 patients, 560 (58.5%) met National Diabetes Data Group criteria and 398 (41.5%) met Carpenter-Coustan only. Compared with untreated women, the direction of treatment effect did not differ by diagnostic criteria used and was consistent with the original trial. The P value for interaction between diagnostic criteria and treatment status was not significant for any outcome. CONCLUSION: The overall beneficial treatment effect on pregnancy-induced hypertension, shoulder dystocia, cesarean delivery, and macrosomia was seen in patients diagnosed by the higher National Diabetes Data Group and by the lower thresholds of the Carpenter-Coustan criteria.

Overview

CoChat Summary

TL;DR

In a secondary analysis of a randomized trial of mild gestational diabetes treatment, women diagnosed by Carpenter-Coustan criteria alone and those meeting the stricter NDDG criteria both appeared to benefit from treatment. The direction of treatment effect was consistent with the original trial, and no significant interaction between diagnostic criteria and treatment was found for any outcome.

Key findings

  • Of 958 women diagnosed with GDM in the primary study, 560 (58.5%) met NDDG criteria and 398 (41.5%) met Carpenter-Coustan criteria only; 931 (97.2%) had outcomes data available.
  • The direction of treatment effect did not differ by diagnostic criteria and was consistent with the original trial; the p-value for interaction between diagnostic criteria and treatment status was not significant for any maternal or neonatal outcome.
  • With the exception of shoulder dystocia, numbers needed to treat were small (20 or less for the overall group) and similar between NDDG and Carpenter-Coustan criteria.
  • The overall beneficial treatment effect on pregnancy-induced hypertension, shoulder dystocia, cesarean delivery, and macrosomia was seen in patients diagnosed by the higher NDDG thresholds and by the lower Carpenter-Coustan thresholds.

Methods

  • Secondary analysis of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network randomized clinical trial for treatment of mild GDM; women at 24 weeks 0 days to 30 weeks 6 days with a 1-hour glucose challenge test of 135–200 mg/dL underwent a 3-hour glucose tolerance test, and mild GDM was defined by fasting glucose <95 mg/dL plus at least two glucose values exceeding Carpenter-Coustan thresholds.
  • Women were randomized to usual care or treatment including nutritional counseling, diet therapy, and insulin if needed; this analysis compared two mutually exclusive groups: those meeting NDDG criteria and those meeting Carpenter-Coustan criteria only.
  • Analysis of variance or the Breslow-Day test for homogeneity was used to test interaction between diagnostic criteria and GDM treatment; number needed to treat was calculated for the overall group, NDDG group, and Carpenter-Coustan group.

Limitations

  • The paper states that stratifying the cohort into two diagnostic criteria groups naturally limited power to detect differences between treated and untreated women within each group, and that lack of statistical power cannot be completely ruled out.
  • The paper states that no adjustments were made for multiple comparisons.
  • Evident from the text: this was a secondary analysis, and outcomes were selected from the primary study for which treatment of mild GDM was beneficial, which may limit inference about outcomes not selected.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1097/aog.0000000000001383

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 0 Not valid · 5 Not checked · 24 Own results and interpretations

15 more claims · 2 with their cited sources checked

Create a free account to see all 40 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 10
  • It may state two separate claims as one. 11

Create a free account to see these claims.

Citations

Cites

Show all 15 references

Research works printed but not linked: 1

  1. 2013, Practice Bulletin No. 137. American College of Obstetricians and Gynecologists., Obstet Gynecol, 122, 406

Cited by

See all 56

Metadata

Authors
Harper, L. M., Mele, L., Landon, M. B., Carpenter, M. W., Ramin, S. M., Reddy, U. M., Casey, B., Wapner, R. J., Varner, M. W., Thorp, J. M., Sciscione, A., Catalano, P., Harper, M., Saade, G., Caritis, S. N., Sorokin, Y., Peaceman, A. M., & Tolosa, J. E.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Northwestern University (US)
Venue
Obstetrics & Gynecology
Published
2016-05
Volume
127
Issue
5
Pages
893-898
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2341996597
Cited by
56
References
16
Citations by year
2026: 5 · 2025: 4 · 2024: 11 · 2023: 3 · 2022: 2 · 2021: 11 · 2020: 8 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 1
FWCI
5.16
Type
journal article
Language
en
Open access
Locations
  • Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR000439)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079626)
  • National Center for Research Resources (C06RR011234, M01RR000080, UL1RR024989, UL1RR025764, M01RR000064, M01RR000034)
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01HD036801, U10HD040544, U10HD034208, U10HD040512, UG1HD034116, UG1HD053097, U10HD027915, U10HD040545, U10HD040560, U10HD027917, U10HD036801, U10HD027860, U10HD021410, U10HD053097, U10HD034116, U10HD040500, U10HD040485, P2CHD050924, U10HD053118, U10HD027869, U10HD034136, UG1HD034208, U24HD036801, UG1HD040500, UG1HD040512, UG1HD027869, UG1HD040544, UG1HD040485, UG1HD027915, UG1HD040560, UG1HD040545)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
gestational diabetes mellitus, Carpenter and Coustan criteria, National Diabetes Data Group criteria, diagnostic criteria, insulin therapy, gestational hypertension, shoulder dystocia, cesarean section, macrosomia, large for gestational age, neonatal outcomes, perinatal outcomes, birth trauma
MeSH terms
Adult, Diabetes Mellitus, Type 2, Female, Humans, Pregnancy, Prenatal Diagnosis, Sensitivity and Specificity, United States, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes. https://app.cochat.ai/papers/10.1097/aog.0000000000001383
The paper
Harper, L. M., Mele, L., Landon, M. B., Carpenter, M. W., Ramin, S. M., Reddy, U. M., Casey, B., Wapner, R. J., Varner, M. W., Thorp, J. M., Sciscione, A., Catalano, P., Harper, M., Saade, G., Caritis, S. N., Sorokin, Y., Peaceman, A. M., & Tolosa, J. E. (2016). Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000001383

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.